2 most recent filings and news items mentioning AEMD. Updated every 60 seconds.
RegulatoryJun 10, 2026Positive
Aethlon Medical reported fiscal year 2026 results and announced progression of its Australian oncology trial into Cohort 3, the final dosing phase, with the first participant treated. The company strengthened its Hemopurifier intellectual property portfolio with new patents exten
View filing at SEC.gov →
BiotechJun 5, 2026Neutral
U.S. State Dept Announces Nearly $38M In Additional Funding Toward The Department's Ongoing Ebola Response Efforts
View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.